Health
Novel Combinations Excite the R/R Hodgkin Lymphoma Treatment Landscape – Targeted Oncology
While the treatment of relapsed or refractory Hodgkin lymphoma has seen novel approaches in recent years improving outcomes for many patients, high-risk patients…
While the treatment of relapsed or refractory (R/R) Hodgkin lymphoma (HL) has seen novel approaches in recent years improving outcomes for many patients, high-risk patients develop progressive disease and have limited treatment options.1
Two studies presented during the 62nd American Society of Hematology Annual Meeting and Exposition explored new therapeutic strategies for this patient population. First, results from a phase 2 study (NCT04052997) suggest that camidanlumab tesirine (ADCT-301) can…
-
Noosa News16 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News14 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News23 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common